ARDT · Ardent Health, Inc.
$10.64
+4.75% last session
End-of-day data · updated 2026-07-28
Market cap
$2B
Enterprise value
$4B
Trailing P/E
11.7
Forward P/E
8.8
Dividend yield
—
Beta
0.75
Avg volume
1M
Employees
20K
2D change
—
5D change
5.09%
10D change
7.88%
30D change
12.54%
60D change
18.63%
MTD change
8.09%
YTD change
24.01%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ARDT
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-14
Latest call per bank · past 12 months
RBC Capital
Outperform$12.00
+12.8% vs priceUBS
Buy$13.50
+26.9% vs priceJP Morgan
Neutral$11.00
+3.4% vs priceMorgan Stanley
Equal-Weight$12.00
+12.8% vs priceBank of America
Underperform$10.00
-6.0% vs priceGoldman Sachs
Neutral$19.00
+78.6% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-14 | Truist Securities | Maintains | Buy | $13.00 → $12.00 |
| 2026-07-09 | RBC Capital | Maintains | Outperform | $13.00 → $12.00 |
| 2026-05-07 | UBS | Maintains | Buy | $13.00 → $13.50 |
| 2026-03-10 | RBC Capital | Maintains | Outperform | $14.00 → $13.00 |
| 2026-03-06 | Leerink Partners | Maintains | Outperform | $16.00 → $15.00 |
| 2026-01-20 | JP Morgan | Maintains | Neutral | $12.00 → $11.00 |
| 2025-12-18 | UBS | Maintains | Buy | $14.50 → $14.00 |
| 2025-12-18 | Mizuho | Maintains | Outperform | $20.00 → $12.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 73 — overbought territory; the recent run-up may be due for a pause.
- Price vs 50-day MA: Trading 17.9% above the 50-day MA ($9.73).
- Price vs 200-day MA: Trading 15.4% above the 200-day MA ($9.94).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+0.09) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($7.83) and high ($15.21).
ARDT Price Chart
Loading chart for ARDT…
Fundamentals
About Ardent Health, Inc.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$86B -16.3% YTD
THC
Tenet Healthcare Corporation
$21B 22.5% YTD
DVA
DaVita Inc.
$15B 108.0% YTD
FMS
Fresenius Medical Care AG
$13B 8.6% YTD
EHC
Encompass Health Corporation
$11B 7.9% YTD
UHS
Universal Health Services, Inc.
$10B -26.8% YTD
ENSG
The Ensign Group, Inc.
$10B 2.3% YTD
CHE
Chemed Corp
$7B 19.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.